XML 48 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1

License and Collaboration Agreements (Tables)

12 Months Ended

Dec. 31, 2017

Organization Consolidation And Presentation Of Financial Statements [Abstract]

License, Collaboration and Other Revenue

In accordance with our collaboration agreements, we recognized license, collaboration and other revenue as follows (in thousands):

				Year Ended December 31,
Partner		Agreement		2017				2016				2015
Eli Lilly and Company		NKTR-358		$	130,087			$	—			$	—
Ophthotech Corporation(1)		Fovista®			19,123				1,408				1,398
Bayer Healthcare LLC(1)		BAY41-6551 (Amikacin Inhale)			17,931				1,429				1,919
Baxalta Incorporated / Shire		ADYNOVATE®			11,443				650				10,694
MAP Pharmaceuticals, Inc. / Allergan		SEMPRANA®			11,000				—				—
Amgen, Inc.		Neulasta®			5,000				5,000				5,000
AstraZeneca AB		MOVANTIK® and MOVANTIK® fixed-dose combination program			4,600				33,000				130,000
Daiichi Sankyo Europe GmbH(1)		ONZEALDTM (NKTR-102)			3,811				3,690				—
Roche(1)		PEGASYS® and MIRCERA®			—				7,685				12,816
Other					7,970				7,520				3,777
License, collaboration and other revenue				$	210,965			$	60,382			$	165,604

(1) These collaboration agreements were completed as of December 31, 2017.

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of contractual arrangements that involve two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity. Additionally, the element may include all other transactions of the entity categorized collectively, if such comparison of collaborative arrangements as a component of all transactions of the entity is desired.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 808
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434

+ Details

Name:	us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration